Region: Global
Category: Diseases & Conditions

Global Diseases & Conditions

(10,714 reports matching your criteria)
  • Global Zika Virus Testing Market Analysis and Forecast 2024-2030

    ... virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint ... Read More

  • Global Drugs for Malaria Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

    ... occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get ... Read More

  • Global Immunomodulators Databank Market Report

    ... segment is expected to be the highest contributor to this market, with $78,020.3 Million in 2020, and is anticipated to reach $151,171.1 Million by 2029, registering a CAGR of 7.67%. Oncology and Respiratory segments collectively ... Read More

  • Global Food Allergy Databank Market Report

    ... 2029. Skin-Prick Tests segment is expected to be the highest contributor to this market, with $3,454.2 Million in 2020, and is anticipated to reach $5,495.8 Million by 2029, registering a CAGR of 5.34%. Blood Test ... Read More

  • Global Multiple Myeloma Therapeutics Databank Market Report

    ... 2021 to 2029. Medication segment is expected to be the highest contributor to this market, with $8,265.9 Million in 2020, and is anticipated to reach $14,610.5 Million by 2029, registering a CAGR of 6.57%. Medication ... Read More

  • Global Diabetes Devices Databank Market Report

    ... 2031. Insulin Delivery Devices segment is expected to be the highest contributor to this market, with $17,489.8 Million in 2022, and is anticipated to reach $27,348.1 Million by 2031, registering a CAGR of 5.14%. Blood ... Read More

  • Global Allergic Rhinitis Databank Market Report

    ... 2029. Perennial Allergic Rhinitis segment is expected to be the highest contributor to this market, with $2,396.7 Million in 2020, and is anticipated to reach $3,946.8 Million by 2029, registering a CAGR of 5.74%. Seasonal ... Read More

  • Global Cancer Supportive Care Drugs Databank Market Report

    ... 6.77% from 2021 to 2029. Bisphosphonates segment is expected to be the highest contributor to this market, with $3,463.6 Million in 2020, and is anticipated to reach $6,456.7 Million by 2029, registering a CAGR of ... Read More

  • Global Food Allergy Diagnostics & Therapeutics Databank Market Report

    ... CAGR of 6.03% from 2023 to 2031. Diagnostic Products segment is expected to be the highest contributor to this market, with $2,241.8 Million in 2022, and is anticipated to reach $3,594.6 Million by 2031, registering ... Read More

  • Global Stomach Cancer Treatment Databank Market Report

    ... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $2,319.0 Million in 2022, and is anticipated to reach $5,613.5 Million by 2031, registering a CAGR of 10.38%. ... Read More

  • Global Next Generation Cancer Diagnostics Databank Market Report

    ... 8.47% from 2023 to 2031. Next-Generation Sequencing segment is expected to be the highest contributor to this market, with $4,346.5 Million in 2022, and is anticipated to reach $9,095.4 Million by 2031, registering a CAGR ... Read More

  • Global Anti-Cancer Drug Databank Market Report

    ... 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $43,423.4 Million in 2022, and is anticipated to reach $75,119.7 Million by 2031, registering a CAGR of 6.32%. Hormonal Therapy ... Read More

  • Global Rare Hemophilia Factors Databank Market Report

    ... 2021 to 2029. Factor II segment is expected to be the highest contributor to this market, with $1,123.8 Million in 2020, and is anticipated to reach $1,801.8 Million by 2029, registering a CAGR of 5.44%. ... Read More

  • Global Zika Virus Testing Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

    ... Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most ... Read More

  • Global Artificial Pancreas Device System Databank Market Report

    ... intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding ... Read More

  • Global Cancer Diagnostics Databank Market Report

    ... 2031. Consumables segment is expected to be the highest contributor to this market, with $167,321.8 Million in 2022, and is anticipated to reach $261,623.1 Million by 2031, registering a CAGR of 5.13%. Instruments segment is ... Read More

  • Global Acute Coronary Syndrome Therapeutic Databank Market Report

    ... 4.44% from 2023 to 2031. Non-St-Elevation Myocardial Infarction segment is expected to be the highest contributor to this market, with $3,528.2 Million in 2022, and is anticipated to reach $4,904.8 Million by 2031, registering a ... Read More

  • Global Hepatitis Diagnostic Test Databank Market Report

    ... 2023 to 2031. Blood tests segment is expected to be the highest contributor to this market, with $2,457.2 Million in 2022, and is anticipated to reach $3,721.6 Million by 2031, registering a CAGR of 4.76%. ... Read More

  • Global Brain Cancer Diagnostics Databank Market Report

    ... 2023 to 2031. Imaging Test segment is expected to be the highest contributor to this market, with $694.7 Million in 2022, and is anticipated to reach $1,223.4 Million by 2031, registering a CAGR of 6.54%. ... Read More

  • Global Drugs for Malaria Market Size, Manufacturers, Opportunities and Forecast to 2030

    ... in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria ... Read More

  • Global Hematologic Malignancies Databank Market Report

    ... 2029. Leukemia segment is expected to be the highest contributor to this market, with $13,172.5 Million in 2020, and is anticipated to reach $25,934.9 Million by 2029, registering a CAGR of 7.87%. Lymphoma segment is ... Read More

  • Global Zika Virus Testing Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

    ... Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika ... Read More

  • Global Zika Virus Testing Market Size, Manufacturers, Opportunities and Forecast to 2030

    ... Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are ... Read More

  • Global Influenza Diagnostics Databank Market Report

    ... 2029. RT-PCR segment is expected to be the highest contributor to this market, with $339.2 Million in 2020, and is anticipated to reach $425.1 Million by 2029, registering a CAGR of 2.58%. Cell Culture segment ... Read More

  • Global Acute Myeloid Leukemia Therapeutics Databank Market Report

    ... 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $8,938.5 Million by 2031, registering ... Read More

Cookie Settings